BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 8608893)

  • 1. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage.
    Cabrera J; Maynar M; Granados R; Gorriz E; Reyes R; Pulido-Duque JM; Rodriguez SanRoman JL; Guerra C; Kravetz D
    Gastroenterology; 1996 Mar; 110(3):832-9. PubMed ID: 8608893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost analysis for the prevention of variceal rebleeding: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of Italian cirrhotic patients.
    Meddi P; Merli M; Lionetti R; De Santis A; Valeriano V; Masini A; Rossi P; Salvatori F; Salerno F; de Franchis R; Capocaccia L; Riggio O
    Hepatology; 1999 Apr; 29(4):1074-7. PubMed ID: 10094949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
    Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.).
    Merli M; Salerno F; Riggio O; de Franchis R; Fiaccadori F; Meddi P; Primignani M; Pedretti G; Maggi A; Capocaccia L; Lovaria A; Ugolotti U; Salvatori F; Bezzi M; Rossi P
    Hepatology; 1998 Jan; 27(1):48-53. PubMed ID: 9425916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding.
    Sauer P; Theilmann L; Stremmel W; Benz C; Richter GM; Stiehl A
    Gastroenterology; 1997 Nov; 113(5):1623-31. PubMed ID: 9352865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balloon-compression endoscopic injection sclerotherapy versus transjugular intrahepatic portosystemic shunt for esophageal variceal rebleeding.
    Wu W; Zhang F; Mei X; Zhang Q; Jin J; Kong D
    Surg Endosc; 2023 Jul; 37(7):5766-5774. PubMed ID: 37147526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
    Jalan R; Elton RA; Redhead DN; Finlayson ND; Hayes PC
    J Hepatol; 1995 Aug; 23(2):123-8. PubMed ID: 7499782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial.
    Pomier-Layrargues G; Villeneuve JP; Deschênes M; Bui B; Perreault P; Fenyves D; Willems B; Marleau D; Bilodeau M; Lafortune M; Dufresne MP
    Gut; 2001 Mar; 48(3):390-6. PubMed ID: 11171831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding.
    Rössle M; Haag K; Ochs A; Sellinger M; Nöldge G; Perarnau JM; Berger E; Blum U; Gabelmann A; Hauenstein K
    N Engl J Med; 1994 Jan; 330(3):165-71. PubMed ID: 8264738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage.
    Jalan R; John TG; Redhead DN; Garden OJ; Simpson KJ; Finlayson ND; Hayes PC
    Am J Gastroenterol; 1995 Nov; 90(11):1932-7. PubMed ID: 7484994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage.
    García-Villarreal L; Martínez-Lagares F; Sierra A; Guevara C; Marrero JM; Jiménez E; Monescillo A; Hernández-Cabrero T; Alonso JM; Fuentes R
    Hepatology; 1999 Jan; 29(1):27-32. PubMed ID: 9862845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis.
    Khan S; Tudur Smith C; Williamson P; Sutton R
    Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD000553. PubMed ID: 17054131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival.
    Li LN; Sun XY; Wang GC; Tian XG; Zhang MY; Jiang KT; Zhang CQ
    J Dig Dis; 2019 Feb; 20(2):89-96. PubMed ID: 30629804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial.
    Cello JP; Ring EJ; Olcott EW; Koch J; Gordon R; Sandhu J; Morgan DR; Ostroff JW; Rockey DC; Bacchetti P; LaBerge J; Lake JR; Somberg K; Doherty C; Davila M; McQuaid K; Wall SD
    Ann Intern Med; 1997 Jun; 126(11):858-65. PubMed ID: 9163286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of transjugular intrahepatic portosystemic shunt with adjunctive embolotherapy with cyanoacrylate for esophageal variceal bleeding.
    Shi Y; Tian X; Hu J; Zhang J; Zhang C; Yang Y; Qin C
    Dig Dis Sci; 2014 Sep; 59(9):2325-32. PubMed ID: 24748182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding.
    Rössle M; Deibert P; Haag K; Ochs A; Olschewski M; Siegerstetter V; Hauenstein KH; Geiger R; Stiepak C; Keller W; Blum HE
    Lancet; 1997 Apr; 349(9058):1043-9. PubMed ID: 9107241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Transjugular Intrahepatic Portosystemic Shunt Plus Variceal Obliteration versus Transjugular Intrahepatic Portosystemic Shunt Alone for the Management of Gastric Varices: Comparative Single-Center Clinical Outcomes.
    Shah KY; Ren A; Simpson RO; Kloster ML; Mikolajczyk A; Bui JT; Lipnik AJ; Niemeyer MM; Ray CE; Gaba RC
    J Vasc Interv Radiol; 2021 Feb; 32(2):282-291.e1. PubMed ID: 33485506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding.
    Tesdal IK; Filser T; Weiss C; Holm E; Dueber C; Jaschke W
    Radiology; 2005 Jul; 236(1):360-7. PubMed ID: 15955858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of transjugular intrahepatic portosystemic shunt for treatment of variceal bleeding in patients with cirrhosis with or without spontaneous portosystemic shunt.
    Leng X; Zhang F; Zhang M; Guo H; Yin X; Xiao J; Wang Y; Zou X; Zhuge Y
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):853-858. PubMed ID: 30633039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.